Bioarctic granted Japanese patent for Parkinson’s disease candidate

Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.

Automate E2E Image Analysis Pipelines

ZEISS arivis Pro - Your End-to-End Scientific Image Analysis Software.

List: The coolest names in biotech

Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...

Deras samarbete ska ge ett pulvervaccin mot influensa

De bägge Uppsalabolagen Abera Bioscience och Orexo inleder ett samarbete för att ta fram vaccin i pulverform mot bland annat influensa.

KI’s freezer fiasco investigated: A chain of failures

A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying...

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Danska läkemedelsfonder investerar i talangfabrik

Novo Nordisk Foundation, Lundbeck Foundation och Leo Foundation investerar 123 miljoner danska kronor, motsvarande omkring 188 miljoner svenska kronor, i ett ny...

Q-linea tar in kapital till fortsatt USA-satsning – ”Har positionerat oss starkt”

Uppsalabolaget Q-linea, som utvecklar produkter för infektionsdiagnostik, har beslutat att ta in upp till 225 miljoner kronor i en nyemission.

It couldn’t be simpler

AI-assisted ZEISS Solution inspects implant coatings automatically.

”We need compatibility“

Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...

Specific proposals and targets top the universities’ desired priorities

What are the universities’ expectations for the update of the national life science strategy? Life Science Sweden posed the question to representatives from Kar...

A new giant among our microscopes

Two technologies in one machine.

Rapid developments in AI – “All stakeholders are struggling to understand it”

Artificial intelligence is being discussed more and more, and developments in the field are moving rapidly. As the Swedish Medical Products Agency testifies, ke...

Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

Norwegian company wins bidding battle for Sensidose

The lengthy battle to acquire medical device company Sensidose is apparently over. Generic medicines company EQL Pharma is pulling out, selling its shares and l...

Ny kontroversiell studie kopplar fetmaläkemedel till självmordstankar

I både EU och USA har misstänkta kopplingar mellan GLP1-analoger och självmordstankar utretts – och avfärdats. Nu väcks frågan till liv igen av en ny studie.

Major investment in women’s health – for a more equal healthcare system

”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...

Lucy Robertshaw: Did you know Stockholm wants to be in top 5 in the world for Life Sciences?

Karolinska Institutet Solna Campus has certainly become the next “Kendall Square”, writes Lucy Robertshaw in a column.

Pharma Outsourcing – Find the Right Partner (2026)

Läkemedelsbolag skänker nödläkemedel till marburgdrabbade Rwanda

Gilead Sciences har beslutat att skänka 5 000 doser av antivirusläkemedlet remdesivir till Rwanda för nödanvändning under det pågående utbrottet av den fruktade...

Starka resultat för genterapi – pausas ändå

En ny genterapi förbättrade synen hos elva av tolv patienter med en extremt sällsynt ärftlig ögonsjukdom. Men trots de starka resultaten i en klinisk studie har...

An increasing number of people are falling ill with TBE – “Much more research is needed”

Tick-borne meningitis, or TBE, is an increasingly common disease in Sweden. Currently, there is a vaccine against the disease but no drugs. Researcher Anna Över...

Lillys fetmaläkemedel godkänns mot sömnapné i USA – men inte i EU

Viktminskningsläkemedlet Zepbound (tirzepatid) godkänns av den amerikanska läkemedelsmyndigheten FDA som den första läkemedelsbehandlingen för måttlig till svår...

The Covid pandemic accelerated the development of cancer vaccine

The Covid pandemic gave a major boost to the vaccine field. The Danish biotech company Expres2ion Biotechnologies, which is developing a vaccine against breast ...